Physiological heating augments the anti‐inflammatory reactions during granulocyte/monocyte apheresis: A in vitro study
暂无分享,去创建一个
[1] C. Weber,et al. Programmed ‘disarming’ of the neutrophil proteome reduces the magnitude of inflammation , 2020, Nature Immunology.
[2] T. Kishimoto,et al. Arid5a Regulation and the Roles of Arid5a in the Inflammatory Response and Disease , 2019, Front. Immunol..
[3] Toshio Tanaka,et al. Targeting Interleukin-6 Signaling in Clinic. , 2019, Immunity.
[4] H. Asao,et al. Adsorption of Soluble Immunoglobulin‐Type Adhesion Molecules to Cellulose Acetate Beads , 2018, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[5] M. Oka,et al. Regulation of inflammatory responses by dynamic subcellular localization of RNA-binding protein Arid5a , 2018, Proceedings of the National Academy of Sciences.
[6] Y. Yamaguchi,et al. Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non‐drug intervention for patients refractory to pharmacologics , 2017, The Journal of dermatology.
[7] M. Garstka,et al. The Controversial C5a Receptor C5aR2: Its Role in Health and Disease , 2017, Journal of immunology research.
[8] H. Asao,et al. Effect of Temperature on Granulocyte and Monocyte Adsorption to Cellulose Acetate Beads , 2017, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[9] S. Yamada,et al. Novel Blood Purification System for Regulating Excessive Immune Reactions in Severe Sepsis and Septic Shock: An Ex Vivo Pilot Study , 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[10] Stephen A. Martin,et al. Effects of Blood Pressure Reduction in Mild Hypertension , 2015, Annals of Internal Medicine.
[11] C. Pfarrer,et al. Effect of epidermal growth factor (EGF) on the phosphorylation of mitogen-activated protein kinase (MAPK) in the bovine oviduct in vitro: Alteration by heat stress , 2015, The Journal of reproduction and development.
[12] S. Barnum. C4a: An Anaphylatoxin in Name Only , 2015, Journal of Innate Immunity.
[13] I. Wakabayashi,et al. Suppression of Th1 cytokine production by a peptide derived from C4b , 2013, Inflammation Research.
[14] Hidetoshi Takahashi,et al. Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis. , 2013, Journal of the American Academy of Dermatology.
[15] I. Wakabayashi,et al. Inhibition of CXCL10 release by monomeric C3bi and C4b , 2012, Clinical and experimental immunology.
[16] I. Wakabayashi,et al. Cellulose acetate beads activate the complement system but inactivate the anaphylatoxins generated. , 2010, Artificial organs.
[17] John D Lambris,et al. Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.
[18] Y. Nishise,et al. Release of Interleukin‐1 Receptor Antagonist by Combining a Leukocyte Adsorption Carrier With Ulinastatin , 2010, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[19] Y. Nishise,et al. Biological Effect of Anaphylatoxin C5a on the Generation of Anti‐inflammatory Substances in Leukocyte Adsorption , 2009, Therapeutic apheresis and dialysis.
[20] C. Gabay,et al. IL‐1, IL‐18, and IL‐33 families of cytokines , 2008, Immunological reviews.
[21] K. Fujimori,et al. Clinical Response Is Associated with Elevated Plasma Interleukin-1 Receptor Antagonist During Selective Granulocyte and Monocyte Apheresis in Patients with Ulcerative Colitis , 2006, Digestive Diseases and Sciences.
[22] A. Saniabadi,et al. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: Cytokine profiles and endoscopic findings , 2006, Inflammatory bowel diseases.
[23] K. Kondo,et al. Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis. , 2006, World journal of gastroenterology.
[24] A. Issekutz,et al. Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. , 2006, The American journal of pathology.
[25] T. Matsui,et al. Adsorptive granulocyte and monocyte apheresis for refractory Crohn’s disease: an open multicenter prospective study , 2004, Journal of Gastroenterology.
[26] A. Saniabadi,et al. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: Evidence for the involvement of plasma IgG, complement C3 and β2 integrin , 2004, Inflammation Research.
[27] P. Ward. The dark side of C5a in sepsis , 2004, Nature Reviews Immunology.
[28] I. Kowalska,et al. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. , 2002, The Journal of clinical endocrinology and metabolism.
[29] K. Kawabata,et al. The role of neutrophil elastase in acute lung injury. , 2002, European journal of pharmacology.
[30] W. Arend. The balance between IL-1 and IL-1Ra in disease. , 2002, Cytokine & growth factor reviews.
[31] Y. Yamashita,et al. Thrombospondin-1 differentially regulates release of IL-6 and IL-10 by human monocytic cell line U937. , 2002, Biochemical and biophysical research communications.
[32] J. Berg,et al. Divergent effects of tumor necrosis factor α on apoptosis of human neutrophils , 2001, Journal of Leukocyte Biology.
[33] S. Yonehara,et al. Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha. , 1993, International immunology.
[34] C. Dinarello,et al. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. , 1992, Blood.
[35] C. Dinarello,et al. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. , 1992, Blood.
[36] S. Snapper,et al. Erratum to: Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakinra Treatment Suggests Further Mechanism for Mucosal Healing , 2017, Journal of Clinical Immunology.
[37] H. Takeda,et al. A multi center study of granulocyte and monocyte adsorption apheresis therapy for ulcerative colitis—Clinical efficacy and production of interleukin‐1 receptor antagonist , 2008, Journal of clinical apheresis.
[38] I. Bjarnason,et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[39] S. Weyer,et al. Divergent effects of tumor necrosis factor alpha on apoptosis of human neutrophils. , 2001, Journal of leukocyte biology.